El índice h5 es el índice h de los artículos publicados en los últimos 5 años completos. Se trata del número mayor h en cuanto a que h artículos publicados entre 2014 - 2018 deben tener al menos h citas cada uno.ocultar
La mediana h5 de una publicación es el número mediano de citas de los artículos que componen el índice h5.ocultar
Título / AutorCitado porAño
Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients with metastatic renal cell carcinoma (mRCC)
A Amin, ER Plimack, JR Infante, MS Ernstoff, B Rini, DF Mcdermott, ...
BJU INTERNATIONAL 114, 2-2
2562014
Inflammation and prostate cancer: the role of interleukin 6 (IL‐6)
DP Nguyen, J Li, AK Tewari
BJU International 113 (6), 986-992
1642014
Propensity matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United States
JJ Leow, S Reese, J Wei, SR Lipsitz, J Bellmunt, QD Trinh, BI Chung, ...
BJU INTERNATIONAL 113, 12-12
1612014
Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes
RK Lee, H Abol‐Enein, W Artibani, B Bochner, G Dalbagni, ...
BJU International 113 (1), 11-23
1522014
Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen‐deprivation therapy: a randomised controlled trial
P Cormie, DA Galvão, N Spry, D Joseph, R Chee, DR Taaffe, ...
BJU International 115 (2), 256-266
1502015
68Ga‐PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment
PJ van Leeuwen, P Stricker, G Hruby, A Kneebone, F Ting, B Thompson, ...
BJU International 117 (5), 732-739
1432016
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta‐analysis
M Gacci, G Corona, L Vignozzi, M Salvi, S Serni, C De Nunzio, A Tubaro, ...
BJU International 115 (1), 24-31
1342015
First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography‐guided biopsies for the diagnosis of localised prostate cancer
P Mozer, M Rouprêt, C Le Cossec, B Granger, E Comperat, A de Gorski, ...
BJU International 115 (1), 50-57
1292015
Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?
JP Grummet, M Weerakoon, S Huang, N Lawrentschuk, M Frydenberg, ...
BJU International 114 (3), 384-388
1252014
Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours
TM Wah, HC Irving, W Gregory, J Cartledge, AD Joyce, PJ Selby
BJU International 113 (3), 416-428
1242014
The social media revolution is changing the conference experience: analytics and trends from eight international meetings
SE Wilkinson, MY Basto, G Perovic, N Lawrentschuk, DG Murphy
BJU International 115 (5), 839-846
1202015
Use of social media in urology: data from the A merican U rological A ssociation (AUA)
S Loeb, CE Bayne, C Frey, BJ Davies, TD Averch, HH Woo, B Stork, ...
BJU International 113 (6), 993-998
1162014
Phase III, randomised, double‐blind, placebo‐controlled study of the β3‐adrenoceptor agonist mirabegron, 50 mg once daily, in J apanese patients with overactive bladder
O Yamaguchi, E Marui, H Kakizaki, Y Homma, Y Igawa, M Takeda, ...
BJU International 113 (6), 951-960
1142014
Prospective evaluation of 68Gallium‐prostate‐specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer
PJ van Leeuwen, L Emmett, B Ho, W Delprado, F Ting, Q Nguyen, ...
BJU International 119 (2), 209-215
1102017
Learning curves for urological procedures: a systematic review
H Abboudi, MS Khan, KA Guru, S Froghi, G de Win, H Van Poppel, ...
BJU International 114 (4), 617-629
1062014
Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)–focus on the UK
M Speakman, R Kirby, S Doyle, C Ioannou
BJU International 115 (4), 508-519
1002015
Recent insights into NF‐κ B signalling pathways and the link between inflammation and prostate cancer
DP Nguyen, J Li, SS Yadav, AK Tewari
BJU International 114 (2), 168-176
1002014
In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12‐core biopsy still necessary in addition to a targeted biopsy?
SS Salami, E Ben‐Levi, O Yaskiv, L Ryniker, B Turkbey, LR Kavoussi, ...
BJU International 115 (4), 562-570
992015
Spine metastases in prostate cancer: comparison of technetium‐99m‐MDP whole‐body bone scintigraphy,[18 F] choline positron emission tomography (PET)/computed tomography (CT) and [18 F] NaF PET/CT
MH Poulsen, H Petersen, PF Høilund‐Carlsen, JS Jakobsen, O Gerke, ...
BJU International 114 (6), 818-823
972014
Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies
JK Logan, S Rais‐Bahrami, B Turkbey, A Gomella, H Amalou, PL Choyke, ...
BJU International 114 (5), 641-652
952014
1 - 20
Las fechas y los recuentos de citas son estimados y se determinan de forma automática mediante un programa informático.